Your session is about to expire
← Back to Search
Psychotherapy
Psychotherapy for Postpartum Depression
N/A
Recruiting
Led By Nili Solomonov, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Mini Mental Status Exam (MMSE) ≤ 1 SD below the mean score for patient's age and education
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Awards & highlights
Study Summary
This trial tests a new therapy to help new moms with postpartum depression. It includes 9 weeks of therapy, done remotely, to examine changes in social isolation, reward processing and depression severity.
Who is the study for?
This trial is for new mothers 4-12 weeks post-delivery who are experiencing postpartum depression, as indicated by a score of ≥10 on the Edinburgh Postnatal Depression Scale. Participants should be either off antidepressants or on a stable dose for at least 8 weeks and speak English well. Those with severe psychiatric conditions other than certain anxiety disorders or specific phobias, using certain psychotropic drugs, or undergoing ongoing psychotherapy are excluded.Check my eligibility
What is being tested?
The study is testing 'Engage & Connect,' a new type of psychotherapy designed to help reduce postpartum depression. It involves 9 weeks of remote therapy sessions aimed at decreasing feelings of social isolation and improving how social rewards are processed, along with measuring changes in the severity of depression.See study design
What are the potential side effects?
Since this trial involves psychotherapy rather than medication, traditional side effects associated with drugs may not apply. However, participants might experience emotional discomfort discussing personal issues during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My mental function test score is slightly below average for my age and education.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Depression, Postpartum
Secondary outcome measures
Mental Depression
Change in Social Reward Processing on STAR task
Trial Design
1Treatment groups
Experimental Treatment
Group I: Engage & ConnectExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,235 Total Patients Enrolled
2 Trials studying Postpartum Depression
390 Patients Enrolled for Postpartum Depression
Nili Solomonov, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
188 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You scored 10 or higher on the Edinburgh Postnatal Depression Scale (EPDS).I am able to understand and agree to the research and treatment plan.I use no more than 0.5 mg of lorazepam daily or less.You have a history of mental health conditions other than major depression, generalized anxiety, persistent depression, or specific phobias.I am currently in psychotherapy, but not more than once every 8 weeks.My mental function test score is slightly below average for my age and education.I have been on a stable dose of antidepressants for 8 weeks and don't plan to change it.If you were pregnant before and had a baby with serious health problems or if the baby was stillborn or died soon after birth, you cannot participate.
Research Study Groups:
This trial has the following groups:- Group 1: Engage & Connect
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for prospective participants in this experiment?
"This trial is currently open for enrolment as per the most recent update on clinicaltrials.gov, which was posted November 7th 2022. Initially, this medical study was made available to potential participants on November 1st of the same year."
Answered by AI
How many participants is this research endeavor seeking to enroll?
"Affirmative. Clinicaltrials.gov provides information that this research is actively enrolling participants; the trial was initially published on November 1st 2022 and has since had an update on July 11th, 2021. 60 patients are being accepted from a single medical centre."
Answered by AI
Who else is applying?
What state do they live in?
New York
What site did they apply to?
Weill Cornell Medicine
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger